Status:

RECRUITING

Genetic Variants and Regulation of Specialized Pro-resolving Mediator

Lead Sponsor:

Queen Mary University of London

Conditions:

Healthy

Inflammatory Disease

Eligibility:

All Genders

18+ years

Brief Summary

Inflammation is the way that the body reacts against infection, injury or illness. An uncontrolled inflammatory response can lead to the development of inflammatory diseases, such as rheumatoid arthri...

Detailed Description

This study aims to identify polymorphisms in SPM-related genes in a South Asian population and assess whether these lead to alterations in the functions of enzymes and proteins encoded by these genes....

Eligibility Criteria

Inclusion

  • Current volunteer of the Genes \& Health program with (test) or without (control) relevant genetic mutations. Genes \& Health is a huge long-term study of 100,000 people of Bangladeshi and Pakistani origin focuses to link genes with health records and to study disease and treatments. When a volunteer participates in this program, they agree to the possibility to be invited for further studies. Gene \& Health program invites volunteers to take part in two regions of the UK: East London and Bradford.

Exclusion

  • Volunteer that has not had their genome sequenced after taking part in Stage 1 of Genes \& Health program.
  • Volunteer with significant genetically inherited conditions.
  • Any abnormality or pre-existing disease which, in the opinion of the investigator, might either expose the subject to risk, or influence the validity of the results.
  • Volunteer that went under surgery and are recovering.
  • Participation in a clinical study of a new chemical entity, biological product or a prescription medicine, or loss of more than 400 mL blood, within the previous 3 months.
  • Presence or history of drug or alcohol abuse.

Key Trial Info

Start Date :

May 6 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 8 2025

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04698291

Start Date

May 6 2021

End Date

December 8 2025

Last Update

December 2 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Queen Mary University of London

London, United Kingdom, EC1M 6BQ